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Abstract:
Objective: Assessing the statistical power to detect suscepti-
bility variants plays a critical role in GWA studies both from
the prospective and retrospective points of view. Power is em-
pirically estimated by simulating phenotypes under a disease
model H1. For this purpose, the “gold” standard consists in si-
mulating genotypes given the phenotypes (e.g. Hapgen). We
introduce here an alternative approach for simulating pheno-
types under H1 that does not require generating new geno-
types for each simulation. Methods: In order to simulate phe-
notypes with a fixed total number of cases and under a given
disease model, we suggest three algorithms: i) a simple re-
jection algorithm; ii) a numerical Markov Chain Monte-Carlo
(MCMC) approach; iii) and an exact and efficient backward
sampling algorithm. In our study, we validated the three al-
gorithms both on a toy-dataset and by comparing them with
Hapgen on a more realistic dataset. As an application, we
then conducted a simulation study on a 1000 Genomes Project
dataset consisting of 629 individuals (314 cases) and 8,048
SNPs from Chromosome X. We arbitrarily defined an additive
disease model with two susceptibility SNPs and an epistatic
effect. Results: The three algorithms are consistent, but back-
ward sampling is dramatically faster than the other two. Our
approach also gives consistent results with Hapgen. Using our
application data, we showed that our limited design requires
a biological a priori to limit the investigated region. We also
proved that epistatic effects can play a significant role even
when simple marker statistics (e.g. trend) are used. We fi-
nally showed that the overall performance of a GWA study
strongly depends on the prevalence of the disease: the larger
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the prevalence, the better the power. Conclusions: Our ap-
proach is a valid alternative to Hapgen-type methods; it is not
only dramatically faster but also has two main advantages: 1)
there is no need for sophisticated genotype models (e.g. ha-
plotype frequencies, or recombination rates); 2) the choice
of the disease model is completely unconstrained (number
of SNPs involved, Gene-Environment interactions, hybrid ge-
netic models, etc.). Our three algorithms are available in an
R package called waffect (“double-u affect”, for weighted af-
fectations).
Introduction
Genome-wide association (GWA) studies are a widely-used
approach for localizing susceptibility variants responsible for
common complex genetic diseases [1]. Such studies involve
investigating a huge number of genetics markers such as sin-
gle nucleotide polymorphisms - SNPs (from hundreds of thou-
sands to millions), for cohorts of cases and controls whose
sizes range from thousands to tens of thousands of individu-
als. GWA studies have met with many successes, most notably
for type 1 and type 2 diabetes, inflammatory bowel disease,
prostate cancer and breast cancer [2].
In GWA studies, very high false positive rates are expected
when there is no correction for multiple testing. Symmetri-
cally, control for true negative rate - or power - is necessary.
Power estimation is the key to evaluate the efficiency of GWA
methods [3]. The correct estimation of both rates must take
into account the existence of high-dependency patterns be-
tween SNPs, or linkage disequilibrium (LD). The accurate es-
timation of the family wise type I error risk in the presence
of LD consists in sampling the H0 distribution through per-
mutations of phenotypes [4]. Thus, any association between
loci and phenotypes is broken. This permutation strategy is
implemented as a gold standard in numerous dedicated pack-
ages, together with software suites designed for GWA studies
[5, 6, 7, 8, 9].
Power is an even more complicated function of several fac-
tors: study design, correlation patterns in the genotypic data,
sizes of cohorts, frequency of the susceptibility allele, relative
risk conferred by the causal factor, genetic model (additive,
dominant, recessive, multiplicative) [10]. As a consequence,
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the analytical computation of power requires simplified as-
sumptions, including the approximation of the test statistic
distribution under H1 through a probability law [11]. Most
power calculators based on analytical approaches are used for
two-stage GWA design, e.g. [12, 13]. Recently, an analytical
approach has been proposed to account for LD, under either
H0 or H1 approximation [14]: a fixed-size sliding window lo-
cally accounts for the inter-marker correlation. This approach
brings an improvement over block-wise strategies by unifying
H0 and H1 processings in the same framework [15, 16, 17].
However, with regards to both accuracy and computational
burden, the optimal choice of window size depends on the
structure of the data. Moreover, LD blocks are often am-
biguous. Thus, the previous sliding window approach cannot
account for high-order dependencies between LD blocks. In
particular, this method cannot be used to evaluate the power
of any novel approach designed to cope with such high order
dependencies in GWA studies. In this case, the only solution
is to use computationally intensive simulations.
Similar to sampling under H0, the simulation of the H1
distribution is an appealing way to keep the LD-structured
genotypic data. These simulations consist in generating case
and control samples which mimic the LD structure in hu-
man genome, i.e. in the creation of, say, k datasets under
the H1 assumption (at least one SNP is a susceptibility SNP).
Nonetheless, breaking any association between a locus (or se-
veral loci) and the phenotype is far easier than to introduce
such an association in a dataset.
Two main strategies have been developed to simulate H1.
(i) The first one [18] consists in first generating a large sam-
ple of haplotypes conditional on reference haplotypes such
as HapMap haplotypes [19]. The haplotypes are then paired
to build diplotypes. The disease status is affected depending
on the penetrance model which involves a susceptibility SNP
selected at random. (ii) The second strategy [3] consists in
first randomly selecting a disease SNP and generating a fixed
number of cases and controls. Then diplotypes are assigned
at the disease SNP for cases and controls depending on the
penetrance model. Finally, haplotypes are built (two for each
diplotype) for all remaining SNPs of the chromosome, condi-
tional on reference haplotypes. Nevertheless, both strategies
entail problems of implementation when applied to power es-
timation in GWA studies. The drawback of the first strategy
is that it does not make it possible to control the number of
cases and controls. To tackle this issue, rejection sampling of
case-control samples can be used, but this leads to a waste of
time and data. An illustration of the first strategy is Fregene
[18]. The second strategy makes it possible to control these
numbers by first fixing them, but requires generating haplo-
types for each simulation. The widely-used simulator Hapgen
[20] implements the second strategy.
To this aim, we propose a new method which randomly as-
signs n1 cases and n0 controls conditional on n = n0 + n1
genotypes and a given disease model. Our idea is to affect
the status of individual i according to both the probability pii
that i is a case and to the constraint that the total number
of cases is fixed. The probability pii is computed from the
disease model and is proportional to the relative risk for in-
dividual i. This method provides several advantages. First, it
generalizes permutations, which is the gold standard for ge-
nerating H0 distributions in order to control type I error in
multiple testing. Indeed, permutations represent a particular
case of our general approach which is obtained by using the
same pii for all individuals. Secondly, our method is faster
than previous ones [3, 21] because it does not require a re-
jection sampling step or the generation of new genotypes for
each simulation. Moreover, in the case of LD modeling-based
mapping methods, LD pattern identification needs to be per-
formed only once. Thirdly, no assumption is made on the
genotype distribution, because the latter is the same for each
simulation. The last advantage is that power can be directly
assessed using real GWA datasets, such as those provided by
the 1000 Genomes Project [22], because disease status can
be generated according to genotypes without loss due to re-
jection sampling. This is most valuable when evaluating the
performance of new mapping methods.
The paper is organized as follows. We first describe the
method itself, which we called waffect, then we validate our
tool on a toy-example and compare its results to Hapgen [20]
simulations. We finally illustrate the interest of our approach
with a power study conducted on real GWA data.
Materials and Methods
Detailed aims and notations
We consider a GWA study with n = n0 + n1 individuals (n0
controls and n1 cases), and p SNPs. The ith phenotype is Yi ∈
{0, 1} (Yi = 1 if individual i is a case, Yi = 0 if individual i is a
control). The ith genotype is Xi ∈ {0, 1, 2}p (this corresponds
to the number of rare alleles for each SNP).
Our disease model, thereafter denoted H1, is defined by the
probability pii = P(Yi = 1|Xi) that individual i is a case condi-
tional on her/his genotype. In the particular case when all pii
have the same non-negative value, the observed genotype has
no effect on the phenotype. This case corresponds to the null
hypothesis H0. In the particular case when we consider a sin-
gle SNP (p = 1), pii takes only three possible values: pii = f0
if Xi = 0, pii = f1 = f0RR1 if Xi = 1, and pii = f2 = f0RR2 if
Xi = 2, where f0, f1 and f2 are the penetrances of the disease
model, and RR1 and RR2 are the relative risks.
It is obviously easy to simulate under H1 using the inde-
pendent Bernoulli distribution B(pii) for each individual. Un-
fortunately, it is quite unlikely that when doing so the case-
control design constraint C = {∑ni=1 Yi = n1} will be ful-
filled.
For this reason, the standard strategy (i.e. Hapgen) con-
sists in simulating genotypes conditional on phenotypes using
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Bayes’ formula:
P(Xi|Yi) = P(Yi|Xi)P(Xi)∑
x P(Yi|Xi = x)P (Xi = x)
=
piiP(Xi)
P(Yi)
.
The advantage of this approach is that constraint C is au-
tomatically fulfilled, whereas the major drawback is that a
genotype distribution P(Xi) must be introduced. In order to
be realistic, this imposes sophisticated modeling using haplo-
type data and recombination rates.
As an alternative, we suggest several ways to simulate phe-
notypes under H1 conditional on the genotypes (which there-
fore remain untouched) while respecting constraint C. To do
so, we introduce the notation Zj =
∑j
i=1 Yi (with Z0 = 0 by
convention) so that the constraint becomes C = {Zn = n1}.
Reject
The first approach is straightforward: 1) draw (Yi)i=1...n
using independent Bernoulli distributions; 2) if constraint C
is fulfilled, retain (Yi)i=1...n as a valid sample; if not, simply
reject it and return to 1). The problem with this algorithm
is that samples will be rejected at rate 1 − P(C). The natural
question is then: how (un-)likely is event C?
P(C) can be computed recursively by introducing the for-
ward quantities: Fi(m) = P(Zi = m). Starting with F0(m)
being equal to 0, except for F0(0) = 1, we get the following
recursive formula for 1 6 i 6 n:
Fi(m) = Fi−1(m− 1)pii + Fi−1(m)(1− pii). (1)
It follows that the probability of the constraint is P(C) =
P (Zn = n1) = Fn(n1).
This approach is easy to understand and implement, howe-
ver it usually has a very low rate of success. This is the case
when the design is large and the piis are low (for instance in
the case of a small prevalence). In practice, its use will be
limited to small toy-examples.
MCMC
In order to overcome this drawback, an interesting idea is
to turn to Markov Chain Monte Carlo (MCMC) techniques
such as the Metropolis-Hastings class of sampling algorithms
[23]. Starting from a configuration of phenotypes fulfilling
the constraint (e.g. with the observed phenotypes), alternate
the following two steps: 1) proposal move: select two individ-
uals i and j such that Yi = 1 and Yj = 0 and then exchange
their phenotypes (Yi = 0 and Yj = 1); 2) accept this move
with rate α given by:
α =
(1− pii)pij
pii(1− pij) .
It can be shown that the sequence of phenotype configura-
tions generated by this algorithm is a Markov chain whose
stationary distribution is our targeted constrained distribu-
tion H1. In practice, the first configurations which are ge-
nerated must be discarded since the Markov chain is not yet
stationary (this stage is called burn-in). In order to obtain a
set of independent configurations under H1, one can either
repeat the burn-in phase of the algorithm as many times as
necessary, or use a sequence of pseudo-independent samples
by picking phenotype configurations after the burn-in once
every fixed number of iterations.
The main advantage of the MCMC approach is that it will
eventually work regardless of the probability of event C. Its
drawback is that the number of iterations for burn-in and
pseudo-independence necessary for good mixing increases at
least linearly with the total number n of individuals. More-
over, the control for stationarity and pseudo-independence is
delicate and the practical choice of burn-in and independence
thresholds usually requires tedious calibration work.
Backward sampling
Our proposed alternative is to turn to exact sampling by
introducing the backward quantities Bi(m) = P(C|Zi = m)
which can be computed recursively like the forward quanti-
ties defined above.
Starting from Bn(m) being equal to 0, except for Bn(n1) =
1, we get the following recursive formula for 1 6 i 6 n:
Bi−1(m) = piiBi(m+ 1) + (1− pii)Bi(m). (2)
One should note that we obtain P(C) = B0(0) in the process.
Then we can sample phenotypes Yi sequentially with the
following probability:
P(Yi = 1|Zi−1 = m, C) = piiBi(m+ 1)
Bi−1(m)
. (3)
Since this expression depends on Zi−1, the corresponding
probability obviously depends on the number of cases seen
by i − 1. In mathematical terms, the sequence (Yi, Zi)i=1...n
is a heterogeneous Markov chain.
H0 simulations
H0 simulations are simply performed by permutating
the phenotypes Yis. A simple way to do this is to uni-
formly choose a permutation σ of {1, . . . , n} by performing
a O(n log n) quicksort algorithm on a sample of n indepen-
dent random variables with a uniform distribution on [0, 1].
For example, this can be achieved through the sample com-
mand in R [24]. Alternatively, one may use waffect with the
same probability pii for all individuals.
Toy-example dataset
For validation purposes, we first considered a toy-example
dataset with p = 1 SNP. The n genotypes Xi have the follo-
wing distribution: 80% have genotype 0, 15% genotype 1,
and 5% genotype 2. With n being a multiple of 20, these
counts are always integers. For our disease model, we con-
sidered the following relative risks: RR1 = 1.5 and RR2 = 2.0
(additive effect of 0.5). We hence obtained the following pen-
etrances: f0, f1 = 1.5f0 and f2 = 2.0f0. In order to explore
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n f0 P(C) Rejection MCMC Backward
20 0.2 4.5 · 10−3 0.4 s 38 s 0.05 s
20 0.1 1.7 · 10−5 1.5 min 38 s 0.05 s
20 0.07 6.7 · 10−7 38.5 min 38 s 0.05 s
20 0.05 2.9 · 10−8 11.2 h 38 s 0.1 s
40 0.2 8.2 · 10−5 17.4 s 1.2 min 0.1 s
100 0.2 8.7 · 10−10 NA 3.2 min 0.2 s
100 0.1 5.8 · 10−22 NA 3.2 min 0.2 s
100 0.01 1.1 · 10−69 NA 3.2 min 0.2 s
Table 1: Running time for generating 100 replicates.
the relevance and limits of each of our three approaches, we
considered a wide range of values for n and f0.
Hapgen simulations
In contrast with simulations under H1, simulations under
H0 are expected to provide few statistically significant results.
This contrast can be observed through a binary (or two-class)
classifier system. Regarding this aspect, we compared the be-
havior of waffect with the one of the widely used simulator
Hapgen [25] under various conditions. The comparison re-
lied on the so-called Receiver Operating Characteristic (ROC)
curve, which is a graphical plot of the true positive classi-
fication rate (sensitivity) as a function of the false positive
rate (specificity), for a continuum of values of a given dis-
crimination criterion. The performance of each simulator is
summarized using the area under the ROC curve (AUC): the
larger the AUC, the more performant the simulator in gene-
rating H1 data contrasting with H0 data (more details about
ROC curves can be found below).
Three input parameters must be specified in Hapgen: i) the
range of the Minor Allele Frequency (MAF) of the simulated
susceptibility SNP; here we considered [0.2, 0.3] or [0.1, 0.2];
ii) the disease prevalence, which we set to 0.01; iii) and the
severity of the disease expressed through the relative risks
RR1 = f1/f0 for individuals heterozygous at the disease SNP,
and RR2 = f2/f0 for homozygous individuals (rare allele).
We considered a total of n = 629 subjects (n0 = 315 con-
trols, n1 = 314 cases) and p = 9, 579 SNPs in the region
delimited by loci 558,390 and 13,930,000 on chromosome
1 (Reference: HapMap files [19], CEU population reference,
http://hapmap.ncbi.nlm.nih.gov/).
For each condition, the penetrances f0, f1 and f2 used
with waffect for comparison purposes were obtained per-
forming several simulations using Hapgen and then averag-
ing the corresponding penetrances. Four datasets were gene-
rated. Each was then submitted to a genome-wide association
study. In the first dataset (Hapgen - H1 hypothesis), Hapgen
provided the genotypes together with the phenotypes. All
the other datasets consisted in the aforesaid genotypic data
together with phenotypes generated as follows. In the sec-
ond dataset (Hapgen - H0 hypothesis), the phenotypes un-
der the H0 hypothesis were generated through the method of
permutations. In the third dataset (waffect - H1 hypothe-
sis) the phenotypes were affected with waffect . Finally, in
the fourth dataset (waffect - H0 hypothesis), we obtained
the replicates by affecting the phenotypes after specifying in
waffect a uniform probability pii accross all individuals (this
is equivalent to permuting the phenotypes). Besides, 1,000
replicates were simulated for each of the four datasets and
under each condition (MAF range and relative risks). In the
end, 64,000 GWA studies were performed (2 MAF ranges ×
8 (RR1, RR2) pairs × 4, 000 datasets). Moreover, the com-
parison of the AUCs obtained for Hapgen and waffect were
performed twice, because we used alternatively two distinct
statistics of association as the discrimination criterion for the
two-class classifier.
1000 Genomes dataset
The dataset consists of the genotypes of n = 629 individuals
(n0 = 315 controls, n1 = 314 cases) from the 1000 Genomes
Project [22]. We focused on the first 100,000 SNPs on chro-
mosome X. In the pretreatment stage, we filtered out all the
SNPs with Minor Allele Frequency (MAF) less than or equal
to 5%, ending up with n = 8, 048 SNPs.
We arbitrarily considered a disease model with two inter-
acting disease SNPs. The two SNPs respectively have the
base-pair positions 627,641 and 1,986,325, MAFs 0.26 and
0.23, and display no linkage disequilibrium (r2 = 0.02). We
considered an additive effect β > 0 and an epistatic effect η
such that:
pii = f0 ×
 1.0 + βX
1
i if X
2
i = 0
1.0 + βX2i if X
1
i = 0
1.0 + η + β(X1i +X
2
i ) if X
1
iX
2
i 6= 0
where X1i and X
2
i correspond to the genotype of individual i
at the two susceptibility SNPs.
Statistics of association
The association signal of each SNP (single marker analy-
sis) is computed through the PLINK software [26] using the
trend statistic. We denote pj the p-value of SNP j. In order
to avoid the multi-testing issue, we considered the following
single real valued statistic:
Sρ = max
j∈Jρ
− log10 pj
where Jρ denotes the subset of SNPs such that the distance
between their loci and the locus of a disease SNP is less than
a radius ρ
For example, S∞ corresponds to taking the best p-value pj
in negative (decimal) log-scale on the whole dataset. With
ρ = 5 kb, we consider the best p-value of the SNPs within 5
kb of one of the two susceptibility SNPs. The radius part of
4
n f0 Rejection MCMC Backward
20 0.2 0.60 0.59 0.61
[0.53, 0.67] [0.52, 0.66] [0.54, 0.68]
20 0.1 0.59 0.59 0.58
[0.52, 0.66] [0.52, 0.66] [0.51, 0.65]
20 0.07 0.62 0.56 0.56
[0.55, 0.69] [0.49, 0.63] [0.49, 0.63]
20 0.05 0.44 0.58 0.53
[0.37, 0.51] [0.51, 0.65] [0.47, 0.60]
40 0.2 0.58 0.62 0.59
[0.50, 0.65] [0.54, 0.69] [0.52, 0.67]
100 0.2 NA 0.75 0.72
[0.68, 0.81] [0.65, 0.79]
100 0.1 NA 0.64 0.68
[0.57, 0.72] [0.61, 0.75]
100 0.01 NA 0.65 0.59
[0.58, 0.73] [0.51, 0.67]
Table 2: AUC and 95% confidence intervals, 100 replicates.
the statistic is somewhat unusual since it takes advantage of
information which is rarely available in practice: the location
of the disease SNPs. However, in our simulation framework,
this information helped us discuss the power of the design
depending on the a priori location of the susceptibility SNPs.
From a general point of view, starting with no a priori leads to
a choice of ρ =∞; after a successful linkage analysis, ρ = 100
kb might be more relevant, and if a candidate gene has been
identified, ρ = 5 kb could be a good choice.
ROC curves and AUC
In order to measure the performance of a given statistic
for a given design and H1 model, it is natural to compare
the sensitivity and specificity of the testing framework for a
given threshold of significance. For example, a global thresh-
old of 5% is commonly accepted as a reasonable choice. It
might be interesting to avoid doing this arbitrary choice by
studying instead the Receiver Operator Characteristic (ROC)
curve which is nothing but a graphical representation of the
specificities and sensitivities that we can obtain for all possi-
ble values of the threshold of significance [27].
The ROC curve itself can then be further summarized by the
Area Under the Curve (AUC) which can be qualitatively inter-
preted as follows: AUC 6 0.6 means “fail”; 0.6 < AUC 6 0.70
means “poor”; 0.7 < AUC 6 0.80 means “fair”; 0.8 < AUC 6
0.9 means “good”; 0.9 < AUC 6 1.0 means “excellent”.
The AUC can easily be estimated from two samples of the
statistic: one sample under H0, and the other under H1. All
ROC curves and AUC computations (including confidence in-
tervals) were performed using the R package pROC [28].
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Figure 1: Comparison of the area under the curves (AUCs) for
Hapgen and Waffect - 1,000 replicates under H1 and 1,000
replicates under H0, respectively, for MAF in [0.2, 0.3], ad-
ditive model, RR1 = 1.6, RR2 = 2.2. The 95% confidence
intervals are indicated.
Results
Validation: toy-example dataset
In Table 1 are depicted the execution times for generating
100 replicates through the rejection, MCMC and backward
sampling algorithms on the toy-example dataset, together
with the corresponding probabilities P(C) of randomly draw-
ing a complete configuration of phenotypes with exactly n1
cases. Different values of n and f0 are considered. P(C) dra-
matically decreases when n grows and f0 becomes smaller. As
a consequence, the running time of the rejection algorithm is
already important (more than 10 hours) even for n as small
as 40 and f0 as large as 0.2. The rejection sampling algo-
rithm was not run for greater values of n as the corresponding
probability of a successful finding is negligible. The MCMC
and backward sampling algorithms have short running times
which grow with n (very gently for the backward algorithm),
and, most importantly, which do not depend on P(C). For the
MCMC algorithm, we considered a burn-in of 105 × n.
The Area Under the Curves and the corresponding 95%
confidence intervals computed on the toy-example dataset
replicates are shown in Table 2. The values found with the
three methods are consistent.
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Figure 2: ROC curves and AUCs at different values ρ of the
radius of the intervals centered in the two disease SNPs.
Validation: Hapgen simulations
First, it has to be noted that even if the number of SNPs
specified in Hapgen is constant across the replicates, the ob-
served number of SNPs varies across these replicates. More-
over, the disease SNP’s MAF and the relative risks observed
in the simulated data fluctuate from one replicate to another
(see the Supplementary Material for explanation).
Figure 1 illustrates the case when the MAF range is [0.2, 0.3]
and the genetic model is additive with RR1 and RR2 values
respectively set to 1.6 and 2.2. Despite the fact that Hapgen
and our approach are not based on the same exact model, we
can see a very good correlation between the two approaches,
suggesting that they give similar results.
In our study (629 subjects, 9,579 SNPs specified in Hap-
gen, Power Edge R900 XEON X7460 2.6 GHz, RAM 128 GB),
the generation and processing of 1,000 replicates required 75
minutes or so using the backward sampling algorithm (under
H1 or H0) or Hapgen under H0. In contrast, under H1 with
Hapgen, 110 hours or so were necessary to generate and pro-
cess data with the same dimension.
More comprehensive comparisons with Hapgen are avail-
able in the Supplementary Material.
Application: Power study on the 1000 Genomes dataset
The ROC curves of the statistics Sρ on the 1000 Genomes
Project dataset for different values of the radius ρ are dis-
played in Figure 2. The AUC is very low (95% CI =
[0.41, 0.57]) when considering all SNPs (ρ = ∞). The AUC
β AUC [95% CI]
0.1 0.62 [0.55, 0.70]
0.2 0.72 [0.64, 0.79]
0.3 0.80 [0.74, 0.86]
0.4 0.90 [0.86, 0.94]
Table 3: AUCs at different values β of additive effect. Fixed
values: f0 = 0.1, epistasis β = 0.3, radius of the candidate
region ρ = 5 kb.
η AUC [95% CI]
0 0.74 [0.67, 0.81]
0.3 0.80 [0.74, 0.86]
0.6 0.85 [0.80, 0.91]
0.9 0.88 [0.83, 0.93]
Table 4: AUCs at different values η of epistasis. Fixed values:
f0 = 0.1, additive effect β = 0.3, radius of the candidate
region ρ = 5 kb.
increases as the region around the two susceptibility SNPs be-
ing investigated gets smaller. In particular, the performance
is good for ρ 6 5 kb. This roughly corresponds to the size
of a gene. These results show that given the design and the
disease model under consideration, the statistic which con-
sists in simply taking the best p-value is successful in detect-
ing a positive signal only in presence of a biological a pri-
ori, thereby narrowing the investigation to the candidate gene
level.
We fixed a candidate region corresponding to the radius
ρ = 5 kb and investigated the dependency of the AUC on the
following parameters: epistasis η, additive effect β, probabi-
lity f0 of being a case in absence of the rare alleles, and total
number n of individuals.
Not unexpectedly, the AUC grows with the additive effect β
(Table 3). More surprisingly, it also grows when the epistatic
effect increases (Table 4) despite the fact that our statistic Sρ
only uses simple marker statistics.
We then focused on the design of the GWA study itself
by studying the effect of the total number of individuals n
on the AUC. This was simply done by doubling (tripling,
quadrupling) the original dataset before applying our di-
sease model. In the case of our configuration of reference
η = 0.3, β = 0.3, f0 = 0.1 and ρ = 5 kb, we observed that the
performance is excellent when the population is twice as large
as the original one (AUC = 0.94 [0.90, 0.97] for n = 1258,
AUC = 0.80 [0.74, 0.86] for n = 629). This gain in power is
even more dramatic when all the SNPs are taken into account
(ρ =∞): the AUC doubles in value when passing from 629 to
1258 individuals (see Table 5).
Finally, we investigated the effect of f0, the probability of
6
n AUC [95% CI]
629 0.49 [0.41, 0.57]
1258 0.78 [0.71, 0.84]
1887 0.92 [0.88, 0.96]
2516 0.93 [0.90, 0.97]
Table 5: AUCs for different sample sizes and on the whole
dataset. Fixed values: epistasis η = 0.3, additive effect β =
0.3, f0 = 0.1.
f0 AUC [95% CI]
0.001 0.73 [0.66, 0.80]
0.01 0.71 [0.64, 0.78]
0.1 0.80 [0.74, 0.86]
0.25 0.94 [0.90, 0.97]
Table 6: AUCs at different values of penetrance f0. Fixed
values: epistasis η = 0.3, additive effect β = 0.3, radius of the
candidate region ρ = 5 kb.
being affected without any exposure, in the design of the
GWA study (note that for small values, f0 is close to the preva-
lence). We can see in Table 6 that small values of f0 result in
smaller AUCs (i.e. AUC = 0.73 [0.66, 0.80] for f0 = 0.001),
while large values of f0 result in much better results (e.g.
AUC = 0.94 [0.90, 0.97] for f = 0.25).
Discussion
Validation
The three algorithms we suggested give similar results but
their performances are quite different. The rejection algo-
rithm has a complexity of O(N/P(C)) to obtain N samples.
This prevents its use in practical cases when P(C) can easily
reach 10−50 or worse. The MCMC approach has the advan-
tage of removing this dependence, and is simple to imple-
ment. The drawback is that the burn-in parameter requires
some calibration work (we suggest to use burn-in = 105n).
Moreover this heavy numerical method is rather slow. In
our study, the backward sampling approach proved to be the
fastest one, dramatically outperforming the MCMC alterna-
tive (i.e. 500 times faster). From a theoretical point of view,
the backward sampling algorithm has a space complexity of
O(n1×n), and a time complexity of O(n1×n+N ×n) where
N is the desired sample size. Our C implementation makes
it possible to generate a configuration of n = 20, 000 phe-
notypes with n1 = 10, 000 cases in 0.2 seconds on a 1.86 Gz
workstation (Xeon E5320, 8 Go RAM, Linux 2.6.35).
Comparison with Hapgen
Our comparison with Hapgen clearly demonstrates that
our approach is a valid alternative to this software. It also
sheds light on the major differences between the two ap-
proaches. First, in order to yield a realistic model for simula-
ting genotypes, Hapgen requires additional information such
as HapMap frequencies and recombination rates whereas our
approach only needs the original genotypes. Regarding our
simulations performed with Hapgen and waffect , running
the newest Hapgen version would have entailed no change in
the results: the newest Hapgen version is an extension of the
former; it is not an improvement (at least regarding single
susceptibility SNP simulation). Indeed, in its initial version,
Hapgen limits the disease model to only one susceptibility
SNP. The most recent version can now simulate multiple di-
sease SNPs, under the assumption that each disease SNP acts
independently and that all such SNPs are in Hardy-Weinberg
equilibrium, which are two strong constraints. Besides, this
novel software, unfortunately only available in the 64 bit ver-
sion, requires the use of an R package to simulate interactions
between the disease SNPs. In contrast, simulating any disease
model is straightforward with our approach, as long as it re-
sults in an individual probability for each individual to be af-
fected. For example, we can consider two or more susceptibil-
ity SNPs, and easily add epistatic effects, Gene-Environment
interactions, the contribution of rare variants, etc. Moreover,
due to the multiple constraints it must take into account, Hap-
gen only respects the specified model on average. As a con-
sequence, the effective MAF and relative risks can vary from
one run to another. Besides, selecting for each Hapgen repli-
cate a different disease SNP entails variations in the number
of SNPs available for the association test (see the Supplemen-
tary Material for more details). Finally, since our approach
only generates a fraction of the data (the phenotypes), it is
outstandingly faster than Hapgen. Furthermore, since with
our approach the genotype remains untouched, any numeri-
cally intensive analysis which is performed on the genotype
table (g.e. LD computations) needs to be performed only once
while with Hapgen it has to be done for each replicate.
Effects
In our application study, we showed how our strategy can
be used to investigate various effects on the performance of a
GWA study. We first pointed out that with the suggested de-
sign, our modest disease model (β = η = 0.3, f0 = 0.1), and
the analysis we chose (simple marker using PLINK), the sig-
nal is only statistically detectable by limiting the region to be
investigated to a 5 kb radius around the susceptibility SNPs.
This clearly shows that the present design is practical only
if previous work (e.g. linkage analysis) suggests candidate
genes.
Then we proved that the AUC increases when either the
additive effect (β) or the epistatic effect (η) increases. While
the result for the additive effect is not surprising, the result for
the epistatic effect is worth commenting upon. Indeed, in our
application, we deliberately stuck to a classical simple marker
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analysis (PLINK using the trend test) which is not designed
to detect epistatic effects. However, our study showed that
the corresponding marginal effects can improve the overall
statistical performance of the analysis even when no specific
effort for the detection of epistasis is performed. It would be
interesting to do further research to compare simple marker
analysis to more complex analysis especially designed to take
into account epistatic effects.
Design
We finally briefly investigated the influence of the design of
the GWA study on its performance. As could be expected, the
total number n of individuals plays a critical role. It might
be interesting however to refine this analysis by also consid-
ering different ratios n1/n0. This is left for further investiga-
tion. We also showed that for a fixed design (fixed number
of cases and controls) the prevalence of the disease (through
f0, which is closely related) has an unexpected effect on the
performance: higher prevalence gives better results. More
investigations might be necessary to understand the reason
behind this observation.
Extensions
One should note that our approach can be extended in se-
veral directions. First, we can easily consider more than two
classes, thus complexifying constraint C. In this case, the re-
jection and MCMC algorithms remain exactly the same. For
backward sampling, one should first affect one class against
the others, and then perform the affectation recursively on
the remaining unaffected classes. The resulting complexity
is O(n × (K − 1)) for the affectation of n individuals into K
classes. As explained above, we can also consider sophisti-
cated genetic models that take into account additional cova-
riates such as environmental exposure or rare variants. Fi-
nally, the extension of our approach to other fields is quite
straightforward. For example, in the analysis of gene ex-
pression, our approach might be used to affect sample status
(e.g. cancer or healthy) conditional on the level of expres-
sion rather than generating expressions through parametric
or non-parametric questionable models as is usually done.
Conclusions
In this paper, we present an alternative to classical simu-
lations under H1 in GWA studies. The idea is to generate
the phenotypes conditional on the existing genotypes with re-
spect to the study design (number of cases). For that purpose,
we suggest three algorithms including the backward sampling
which mimics Hidden Markov Models to provide a fast sam-
pling conditional on the constraint. Our study shows that
our algorithms are valid and that their results are consistent
with reference software such as Hapgen. Moreover, our ap-
proach has many advantages: it is much faster; it does not
need any genotyping model (genotypes remain untouched);
it makes it possible to consider any complex genetic model
(including several SNPs, epistasis, covariates, rare variants,
etc.). Our approaches are available in an R package called
waffect (“double-u affect”, for weighted affectations). The
beta version can be downloaded from
www.math-info.univ-paris5.fr/~vperduca .
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Appendix
In this section we give the proofs of the mathematical re-
sults from the Material and Methods section, namely of equa-
tions (1), (2) and (3). Recall that Zj =
∑j
i=1 Yi is the
number of cases among individuals 1, . . . , j and that we deal
with constraint C = {Zn = n1}. The forward and back-
ward quantities are the probabilities Fi(m) = P(Zi = m)
and Bi(m) = P(C|Zi = m). Let V be the set of variables
{Y1, . . . , Yn, Z1, . . . , Zn}.
The key property is that the conditional dependencies
among all the variables determine the following factorization
of the joint probability distribution
P(V ) =
∏
j∈I
P(Zj |Zj−1, Yj)P(Yj), (4)
where I = {1, . . . , n} is the set of all the individuals and Z0 =
0 by convention.
Theorem 1. For each individual i = 1, . . . , n:
P(Zi = m, C) = Fi(m)Bi(m). (5)
Moreover
P(Yi = 1, Zi = m+ 1, Zi−1 = m, C) =
Fi−1(m)piiBi(m+ 1), (6)
P(Yi = 0, Zi = m,Zi−1 = m, C) =
Fi−1(m)(1− pii)Bi(m). (7)
Proof. We will only prove Eq. (5): similar arguments hold
for equations (6) and (7). The marginal probability P(Zi =
m, C) is obtained from the joint probability distribution P(V )
multiplying it by the indicator function 1C (by definition 1C =
1 if and only if C is true) and summing out all the variables in
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V \ {Zi} = {Z1, . . . , Zi−1, Zi+1, . . . , Zn, Y1, . . . , Yn}. Because
of Eq. (4), we have
P(Zi = m, C) =
∑
V \{Zi}
1C
∏
j∈I
Qj(Zj , Zj−1, Yj), (8)
where for convenience we denote Qj(Zj , Zj−1, Yj) =
P(Zj |Zj−1, Yj)P(Yj).
Now consider the sets
V1:i := {Z1, Y1, . . . , Zi, Yi},
V(i+1):n := {Zi+1, Yi+1, . . . , Zn, Yn}.
V1:i ∪ V(i+1):n is a partition of V and V \ {Zi} = V1:j −{Zi} ∪
V(i+1):n.
Note that Eq. (8) is equal to
∑
V1:i\{Zi}
∏
1≤j≤i
Qj
 ∑
V(i+1):n
1C
∏
i+1≤j≤n
Qj
 =
 ∑
V1:i\{Zi}
∏
1≤j≤i
Qj
 ·
 ∑
V(i+1):n
1C
∏
i+1≤j≤n
Qj
 ,
where the last equality holds because the only variable shared
between the two factors is Zi which is set to be Zi = m from
the beginning. It is now easy to see that the two factors in the
product above are Fi(m) and Bi(m) respectively.
Corollary 2. The equations (6) and (7) make it possible to
compute the forward and backward quantities recursively:
Fi(m) = Fi−1(m− 1)pii + Fi−1(m)(1− pii),
Bi−1(m) = piiBi(m+ 1) + (1− pii)Bi(m).
Proof. We will prove only the recursive formula for Bi, a si-
milar argument holds for Fi. Note that
P(Zi = m, C) = Fi(m)pii+1Bi+1(m+ 1)
+ Fi(m)(1− pii+1)Bi+1(m) = Fi(m)Bi(m)
By dividing by Fi(m), we obtain the iterative formula for
the backward quantities.
Corollary 3. We can now prove Eq. (3):
P(Yi = 1|Zi−1 = m, C) = piiBi(m+ 1)
Bi−1(m)
,
for each individual i = 1, . . . , n.
Proof. Apply the definition of conditional probability and di-
vide Eq. (6) by Eq. (5).
Corollary 4.
P(Yi = 1|C) ∝
∑
m
Fi(m)piiBi(m+ 1),
P(Y1 = 0|C) ∝
∑
m
Fi−1(m)(1− pii)Bi(m).
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